Compare with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs CADILA HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES CADILA HEALTHCARE ALKEM LABORATORIES/
CADILA HEALTHCARE
 
P/E (TTM) x 23.9 17.2 138.8% View Chart
P/BV x 5.7 3.1 181.5% View Chart
Dividend Yield % 0.9 0.9 97.2%  

Financials

 ALKEM LABORATORIES   CADILA HEALTHCARE
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-21
CADILA HEALTHCARE
Mar-21
ALKEM LABORATORIES/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3,150509 618.4%   
Low Rs2,224259 859.8%   
Sales per share (Unadj.) Rs741.4147.5 502.6%  
Earnings per share (Unadj.) Rs135.320.9 648.0%  
Cash flow per share (Unadj.) Rs158.328.0 566.0%  
Dividends per share (Unadj.) Rs30.003.50 857.1%  
Avg Dividend yield %1.10.9 122.5%  
Book value per share (Unadj.) Rs616.8126.9 486.0%  
Shares outstanding (eoy) m119.571,023.74 11.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.62.6 139.2%   
Avg P/E ratio x19.918.4 108.0%  
P/CF ratio (eoy) x17.013.7 123.6%  
Price / Book Value ratio x4.43.0 144.0%  
Dividend payout %22.216.8 132.3%   
Avg Mkt Cap Rs m321,244393,092 81.7%   
No. of employees `000NANA-   
Total wages/salary Rs m16,21022,548 71.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m88,650151,022 58.7%  
Other income Rs m2,332449 519.4%   
Total revenues Rs m90,982151,471 60.1%   
Gross profit Rs m19,42431,335 62.0%  
Depreciation Rs m2,7467,248 37.9%   
Interest Rs m5891,688 34.9%   
Profit before tax Rs m18,42122,848 80.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2431,472 152.4%   
Profit after tax Rs m16,17821,376 75.7%  
Gross profit margin %21.920.7 105.6%  
Effective tax rate %12.26.4 189.0%   
Net profit margin %18.214.2 128.9%  
BALANCE SHEET DATA
Current assets Rs m69,28887,160 79.5%   
Current liabilities Rs m36,04178,613 45.8%   
Net working cap to sales %37.55.7 662.7%  
Current ratio x1.91.1 173.4%  
Inventory Days Days2033 58.8%  
Debtors Days Days6676 87.6%  
Net fixed assets Rs m34,825140,943 24.7%   
Share capital Rs m2391,024 23.3%   
"Free" reserves Rs m73,517128,899 57.0%   
Net worth Rs m73,756129,923 56.8%   
Long term debt Rs m3436,095 5.6%   
Total assets Rs m104,114228,103 45.6%  
Interest coverage x32.314.5 222.0%   
Debt to equity ratio x00 9.9%  
Sales to assets ratio x0.90.7 128.6%   
Return on assets %16.110.1 159.3%  
Return on equity %21.916.5 133.3%  
Return on capital %25.718.0 142.2%  
Exports to sales %22.10-   
Imports to sales %010.5 0.0%   
Exports (fob) Rs m19,555NA-   
Imports (cif) Rs mNA15,911 0.0%   
Fx inflow Rs m19,55563,535 30.8%   
Fx outflow Rs m2,46715,911 15.5%   
Net fx Rs m17,08847,624 35.9%   
CASH FLOW
From Operations Rs m12,64932,930 38.4%  
From Investments Rs m-9,985-7,225 138.2%  
From Financial Activity Rs m-2,718-25,489 10.7%  
Net Cashflow Rs m-17-905 1.9%  

Share Holding

Indian Promoters % 57.1 74.9 76.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.3 15.7 123.5%  
FIIs % 5.4 3.8 142.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 25.1 170.7%  
Shareholders   86,881 370,931 23.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

5 Reasons Why Sensex Crashed 1,546 Points Today(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red. The sell-off continued for the fifth straight session today with benchmark indices losing nearly 3% each.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 35.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 35.0% YoY). Sales on the other hand came in at Rs 40 bn (up 14.5% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of CADILA HEALTHCARE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Cadila Healthcare Reports 73% Rise in Profits (Views On News)

May 28, 2021

A look into the company's quarter four financial performance.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 24, 2022 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - HEMO ORGANIC COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS